Acute toxicity of cyclooxygenase-2 inhibitor rofecoxib as a radiosensitizer for concurrent chemoradiation in the treatment of uterine cervical cancer

OBJECTIVE: To evaluate the acute toxicity of rofecoxib during concurrent use with cisplatin-based chemoradiotherapy (CCRT) in patients with cervical cancer. METHODS: We evaluated 67 FIGO stage IB2-IVA cervical cancer patients treated with CCRT between June 2002 and July 2004. The study group include...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jung, Yong Wook, Lee, San Hui, Paek, Ji Heum, Nam, Eun Ji, Kim, Sang Wun, Kim, Jae Hoon, Kim, Jae Wook, Kim, Young Tae
Formato: Artigo
Lenguaje:Inglês
Publicado: Korean Society of Gynecologic Oncology and Colposcopy 2009
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2757559/
https://ncbi.nlm.nih.gov/pubmed/19809548
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3802/jgo.2009.20.3.151
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares